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ABSTRACT
Merkel cells (MCs) are cutaneous specialized cells with a wide immunohistochemical profile, including low
molecular weight cytokeratins and various endocrine and neural markers. Differences in expression of
these markers may be a consequence of contradictory results in studies of MCs in normal and damaged
canine tissues. The present study aimed to compare five different commercial available antibodies
developed against cytokeratins 8 + 18 and 20, neuron-specific enolase, chromogranin A, and
synaptophysin on formalin-fixed paraffin-embedded samples of hard palate, cheek skin including sinus
hair follicles or vibrissae, nasal planum, and footpads. The antibodies showed great variability with respect
to quality and intensity of immunoreactivity to identify MCs. Anti-Cytokeratin 20 antibody is more effective
to recognize MCs in the dog skin followed by the antibodies against neuron-specific enolase, cytokeratins
8 and18, chromogranin A, and synaptophysin. There was also a significant difference in intensity of
immunoreaction scores between them depending on the location examined. These results represent a
necessary basic background for future studies of the role of these cells in normal and damaged canine tissues.
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Merkel cells (MCs) were first described in 1875 by Friedrich
Sigmund Merkel as ‘tastzellen’ (touch cells). These specialized
clear cells function as slowly adapting type-I mechanoreceptors
and are concentrated in touch-sensitive areas in glabrous and
hairy skin and in ectoderm-derived mucosa (Merkel 1875; Halata
et al. 2010; Maksimovic et al. 2014). In addition, MCs are believed
to be involved in paracrine functions related to skin homeostasis
and cutaneous nerve development (Tachibana 1995; Boulais et al.
2009). They contain a plethora of active molecules known to be
neurotransmitters, biogenic monoamines, endocrine and neuro-
crine substances, neurotrophins, or growth and differentiation
factors for various cell types, such as neuron-specific enolase
(NSE), synaptophysin (SYN), chromogranin A (CGA), vasoactive
intestinal polypeptide, bombesin, met-enkephalin, serotonin,
pancreastatin, substance P, peptide histidina isoleucine, and calci-
tonin gene-related peptide (Gauweiler et al. 1988; Hartschuh et al.
1989; Fantini & Johansson 1995; Tachibana 1995). These findings
justified the classification of mammalian MCs with the diffuse
neuroendocrine system. On the other hand, MCs also express
cytokeratin polypeptides demonstrating their epithelial cell char-
acter, including lowmolecularweight cytokeratins (CK) 7, 8, 18, 19,
and 20 (Moll et al. 1984, 1995; Narisawa et al. 1992; Lundquist et al.
1999; Eispert et al. 2009).
Since the immunohistochemical profile of canine MCs also
appears to be wide (Ramírez et al. 2014), it would be of interest
to study whether differences in the identification and number
of canine MCs could be found using different available commer-
cial antibodies in the same tissues. The selection of the most
sensitive and specific antibody is crucial to the selection of
the most appropriate markers for diagnostic purposes and to
perform studies of density and anatomical mapping in cell
populations. The aim of the present study was to compare
the immunohistochemical expression of five commercially
available monoclonal and polyclonal antibodies developed
against low molecular weight cytokeratins and neuroendocrine
molecules, in order to determine possible differences in terms
of immunoreaction and counting of MCs that allow selecting
the most reliable antibody for study of density and distribution
of MCs and their neoplasms in the dog.
Material and methods
Sample selection and tissue preparation
Five, male and female, healthy young adult dogs were used for
the study. They had been humanely euthanized and destined
for academic training according to current legislation (RD53/
2013 from Spanish Government and 2010/63/UE Policy from
European Union on the Protection of Animals Used for Scientific
Purposes). Samples from body locations reported to be MC-rich
areas (Tachibana 1995; Halata et al. 2010) were collected: hard
palate, cheek skin including vibrissae, nasal planum, and
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footpads. The macroscopic appearance of the tissues included
had been normal. Specimens were fixed in 10% neutral buf-
fered formalin, dehydrated through graded alcohols, and
embedded in paraffin wax. Control samples were also obtained
from autopsies, fixed in 10% neutral buffered formalin, and
embedded in paraffin wax (Table 1). Sections that were 3 µm
thick from each location were stained with haematoxylin and
eosin (HE) and were examined to corroborate the absence of
pathologic changes.
Antibody specificity testing and optimization
Samples from oral mucosa and positive control tissues were
used for assay optimization. Five different commercial anti-
bodies were chosen for comparative analysis (Ks20.8, NCL-
5D3, BBS/NC/VI-H14, anti-CgA, and SY38 antibodies; for a
detailed description see Table 1) and were tested with a rig-
orous set of varying assay conditions, including different
antigen retrieval methods (water bath-heating in citrate-
based buffer at 80, 90, and 95°C, microwave-heating in
citrate-based buffer at 15, 20, and 30 min, either alone or in
combination with digestion by proteinase-K at 5, 7, and
10 min), antibody dilutions (ranged from 1:10 to 1:5000),
and antibody time of incubation (ranged from 1 h to over-
night/18 h) in order to determine the optimal conditions to
enhance each antibody’s performance. Upon determination
of preliminary assays, staining patterns in control and test
tissues were compared.
Progressive iterative steps were employed based on the
results of prior staining runs to identify the conditions that
demonstrated accurate cellular localization of each antigen,
an appropriate signal-to-noise ratio, and acceptable perform-
ance in positive and negative tissue controls.
Immunohistochemical protocol
Serial tissue sections that were 3 µm thick were collected onto
Vectabond-coated slides (Sigma Diagnostics, St Louis, MO, USA),
incubated at 37°C for 24 h, deparaffinized, rehydrated in graded
alcohols, and incubated with 3% hydrogen peroxide in metha-
nol for 30 min to block endogenous peroxidase activity. The
sections were then subjected to heat-induced antigen retrieval
by placing in 1 mmol/litre ethylenediamininetetraacetic acid
(Sigma-Aldrich Chemical Co., St Louis, MO, USA) at pH 6.0 in a
water bath at 95°C for 30 min. After cooling, the slides were
covered with 10% normal rabbit (for monoclonal antibodies)
or porcine (for polyclonal antibodies) sera in phosphate buf-
fered saline (PBS) for 30 min at room temperature before incu-
bation with the primary antibodies for 18 h at 4°C. Technical
data of primary antibodies are listed in Table 1. Expression of
these antibodies by MCs had been previously tested (Ramírez
et al. 2014).
A biotinylated rabbit anti-mouse immunoglobulin G (IgG;
Dako, Glostrup, Denmark) diluted 1:200 in PBS containing 1%
normal rabbit serum (for monoclonal antibodies) or a biotiny-
lated porcine anti-mouse immunoglobulin G (IgG; Dako)
diluted 1:200 in PBS containing 1% normal porcine serum (for
polyclonal antibodies) was applied for 30 min at room tempera-
ture as secondary antibody. The avidin-biotin-peroxidase
complex (ABC) (Vector Laboratories, Burlingame, CA, USA) was
then applied as labelling and amplification reagent. To bring
out the immunoreaction, 3-amino-9-ethylcarbazole (AEC)
(Sigma-Aldrich Chemical Co.) was applied to the slides for
3 min at room temperature. Sections were lightly counter-
stained with Mayer’s haematoxylin, washed in tap water, and
aqueous mounted (Shandon Immu-Mount™, Thermo Electron
Corporation, PA, USA).
Evaluation of immunohistochemistry
Positive immunoreactivity was characterized by the presence
of a distinct cytoplasmic red reaction without background
staining. The immunostaining was evaluated separately and
results based on the consensus of board-certified pathol-
ogists (GAR, AE). The numerical frequency of MCs was
assessed by counting the number of positive cells per 1 cm
length of epidermis at 400× magnification. Cells were regis-
tered when the nucleus-containing cell body was visible on
the microscopic field, while cytoplasmic processes or partial
cross-sections were discharged. Results were expressed as
number of MCs per centimetre of basal zone (MCs/cm). The
intensity of immunoreaction for every positive cell was evalu-
ated at 1000x magnification and reported in a four-point
scale (0 = no expression, 1 = mild expression, 2 = moderate
expression, 3 = strong expression). Mean values were
obtained for each location under study. Positive control
tissues (Table 1), along with hematoxylin and eosin-stained
and negative reagent control slides, were used as an aid to
the scoring in every assay.
Statistical methods
Statistical analysis was performed using the IBM SPSS® 20 soft-
ware package (IBM Corporation, Armonk, NY, USA). For the
quantitative parameters, the mean and standard deviation
(SD) were analysed. The number of positive cells and the inten-
sity scores were compared between the five antibodies by one-
way ANOVA test. Statistical significance was accepted at p < .05.
Tukey’s HSD (honest significant difference) test was used in con-
junction with the ANOVA (post hoc analysis) to find means that
are significantly different from each other.
Results
MCs were not differentiated from other epidermal clear cell
populations by HE stain. Some cells were believed to be
MCs by their morphology and location in sinus hair follicles.
Round or oval MCs were detected in 98/100 tissue sections
by immunohistochemistry. They were placed individualized
or clustered in various arrangements at the tips of epithelial
pegs of the palatine mucosa, rete ridges of glabrous skin of
the nasal planum and footpads, and at the base of the epider-
mal discs and within the outer root sheath of the hair follicles
in cheek hairy skin. Several patterns of cytoplasmic immunor-
eactivity were noted depending on the antibody used; nuclei
were not stained with any antibody used. CK20 and CK8 + 18
presented a similar pattern of immunostaining, predominantly
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diffuse, and homogeneously distributed throughout the cell
cytoplasm (Figure 1(a, b)). Occasionally, granular or peripheral
cytoplasmic staining was noted. The staining pattern with the
anti-NSE antibody was light granular and homogeneously dis-
tributed in the cytoplasm (Figure 1(c)). Dermal immunostained
nerve fibres penetrated the basement membrane and were
closely associated with many immunostained cells. CGA was
expressed in a predominantly granular pattern with the stron-
gest immunoreactivity on the basal side of the epidermal and
mucosal MCs or on the side facing the follicle in MCs of vibris-
sae (Figure 1(d)). The immunoreactivity for SYN presented as
finely granular immunostaining localized in the superficial
face of the cytoplasm in the epidermal and mucosal MCs
whereas it was situated in the dermal face in the MCs of vibris-
sae (Figure 1(e)). Some nerve bundles and perivascular immu-
nostained nerve fibres in dermis were also positive for CGA
and SYN antibodies.
The intensity scores and counting of immunopositive cells
are summarized in Tables 2 and 3, respectively. Differences
in the intensity of immunoreaction for each antibody were
noted between MCs in the same or in different locations in
the same individual. Acceptance of the assay was based on
the consistency in staining patterns and a coefficient of vari-
ation (CV) among sample scores that does not exceed 20%.
In hard palate and nasal planum, the strongest immunoreac-
tion was obtained for CK20 (2.5 ± 0.4 and 2.5 ± 0.3 scoring,
respectively), followed by NSE (2.3 ± 0.6 and 2.3 ± 0.4), CK8 +
18 (1.7 ± 0.4 and 1.5 ± 0.4), CGA (1.5 ± 0.6 and 1.5 ± 0.6), and
SYN (1.4 ± 0.4 and 1.3 ± 0.4). In cheek skin and footpads, the
intensity of immunoreaction was very similar for CK20 (2 ±
0.4 and 2.3 ± 0.3 scoring, respectively), NSE (2 ± 0.4 and 2.3 ±
0.4), and CGA (2.3 ± 0.5 and 2.3 ± 0.4), and stronger than
CK8 + 18 (1.9 ± 0.5 and 1.8 ± 0.3) and SYN immunostaining
(1.4 ± 0.3 and 1 ± 0.3) (Figure 1). These scores were found to
be statistically comparable. In the hard palate, differences in
intensity of immunoreaction were statistically significant
between CK20 and CGA (p = .03), and CK20 and SYN (p
= .01). In the cheek skin, only significant differences were
noted between CGA and SYN (p = .02). Differences in immu-
noreaction scores were also present in the nasal planum for
CK20 compared with CK8 + 18 (p = .04), CGA (p = .04), and
SYN (p < .01), and for NSE compared with SYN (p = .02).
Finally, difference in reaction intensity with SYN was highly sig-
nificant when compared with CK20 and CGA scores (p < .01) in
the footpads. The CV for each sample set and antibody is pre-
sented in Table 2. Only the antibody anti-CK20 showed con-
sistently a CV≤ 20% (average 12–20%).
Our results also reveal variations in density of MCs between
locations and antibodies used. For every location, the highest
numbers of MCs/cm of basal zone were consistently obtained
with anti-CK20 antibody (Table 3). These differences in MC
numbers between the antibodies tested were not statistically
significant, excepting in footpads between CK20 and SYN (p
< .01), NSE and SYN (p = .03), and CGA and SYN (p = .02).
Discussion
The highest numbers of MCs were identified using the anti-
CK20 antibody for each location under study. Differences up
to 2-fold in the MCs-counting were found for the same anatom-
ical location between the markers, especially between the anti-
CK20 and anti-SYN antibodies. In addition, intensity of
Table 1. Technical data of antibodies and immunohistochemical procedures.
Antibodya Clon Type Manufacturerb Ag retrieval Dilution Positive controls
CK20 Ks20.8 M Dako HIER 1:40 Human and canine intestinal epithelium
CK8 + 18 NCL-5D3 M EuroDiagnostica HIER 1:20 Canine sweat gland epithelium
NSE BBS/NC/VI-H14 M Dako HIER 1:1000 Canine brain
CGA – P Dako HIER 1:50 Human and canine colon
SYN SY38 M Dako HIER 1:20 Canine adrenal medulla
Note: M =monoclonal; P = polyclonal; Ag = antigen; HIER: Heat-induced epitope retrieval.
aSee text for abbreviations.
bDako Labs., Glostrup, Dinamarca; EuroDiagnostica Labs., Malmö, Sweden.




Mean ± SD CV (%)1 2 3 4 5
CK20 Hard palate 2.5 1.8 3 2.8 2.6 2.5 ± 0.4 16
Nasal planum 2.9 2.3 2.9 2.6 1.6 2.5 ± 0.3 12
Cheek skin 2 1.7 1.8 2.8 1.6 2 ± 0.4 20
Footpads 2.1 2.2 2 2.8 2.5 2.3 ± 0.3 13.1
CK8 + 18 Hard palate 1.7 2 1 1.7 2 1.7 ± 0.4 23.5
Nasal planum 1.3 1.6 2 1.7 1 1.5 ± 0.4 26.7
Cheek skin 2.3 1.5 2.3 2.2 1.2 1.9 ± 0.5 26.3
Footpads 1.6 2 2 1.3 2 1.8 ± 0.3 16.7
NSE Hard palate 2.7 1.3 2.6 2.7 1.9 2.3 ± 0.6 26.1
Nasal planum 2 2.1 2 2.6 2.8 2.3 ± 0.4 17.4
Cheek skin 1.7 1.5 2.5 1.8 2.5 2 ± 0.4 20
Footpads 2.3 1.9 0 2.5 2.5 2.3 ± 0.4 17.4
CGA Hard palate 2 1.2 1 1.2 2.3 1.5 ± 0.6 40
Nasal planum 2.4 1 1 1.9 1.3 1.5 ± 0.6 40
Cheek skin 2.6 2.7 2.1 2.6 1.6 2.3 ± 0.5 21.7
Footpads 2.5 2.3 2.5 2.3 1.9 2.3 ± 0.4 17.4
SYN Hard palate 1 1.5 2 1.4 1 1.4 ± 0.4 28.6
Nasal planum 2 1 1.2 1.1 1 1.3 ± 0.4 31
Cheek skin 1.1 1.3 1.1 1.6 1.7 1.4 ± 0.3 21
Footpads 1 1 0 1 1 1 ± 0.3 30
Note: ATB = antibody; SD = standard deviation; CV = coefficient of variation.
Figure 1. Serial histologic sections of vibrissa showing cytoplasmic immunoreac-
tivity in the MCs for CK20 (a), CK8 + 18 (b), NSE (c), CGA (d), and SYN (e) antibodies.
ABC immunohistochemical staining. 400×.
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immunoreaction was usually more intense for CK20 than for
other antibodies tested. CV was ≤20% with the use of the
anti-CK20 antibody, indicating that the results are more homo-
geneous than those obtained with any of the other antibodies
tested. These findings are in agreement with the sensitivity and
specificity for MCs’ identification demonstrated for antibodies
against CK20 in humans (Moll et al. 1995) and rodents (Moll
et al. 1996).
The pattern of immunostaining in MCs was different for each
antibody used. These differences of immunostaining are due to
the intracellular location of the specific peptide against which
each antibody is directed. Cytokeratins are integral constituents
of the cytoskeleton in the mammalian MCs (Eispert et al. 2009;
Halata et al. 2010). Immunoreactive products in the MCs
labelled with anti-cytokeratin antibodies appear to be homoge-
neously distributed within the cytoplasm, matching with the
typical arrangement of cytokeratins in the form of fine inter-
mediate filaments distributed within the cell (Halata et al.
2010; Ramírez et al. 2015). In addition, being the structural
cytoskeleton, CKs in the MCs seem to be participating in the
cell plasticity necessary for mechanoreceptive function
(Eispert et al. 2009). In the NSE-positive cells, the immunoreac-
tion was dispersed throughout the cytoplasm in correspon-
dence to the distribution of ribosomes and the rough
endoplasmic reticulum observed in the MCs under electron
microscopy (Gu et al. 1981; Vinores et al. 1984; Ramírez et al.
2015). It has been noted that the number of ribosomes per
cell varies with the cell cycle (Darzynkiewicz et al. 1979); there-
fore NSE expression by MCs may be different depending on the
cell status.
CGA is the main element of the soluble matrix protein in
secretory granules of various neuroendocrine cells, including
mammalian MCs, usually coexisting with other neuropeptides
such as VIP, peptide histidine isoleucine, substance P, or CGRP
in the same granule (Gauweiler et al. 1988; Hartschuh et al.
1989; Fantini & Johansson 1995). Using anti-CGA antibody,
immunostaining in MCs of the dog was restricted to the
cytoplasmic portion closest to the nerve ending where dense-
core granules are concentrated (Ramírez et al. 2015). SYN, a
specific component of the membrane of presynaptic vesicles
in neurons and neuromuscular junctions (Ortonne et al. 1988),
showed a cytoplasmic immunostaining pattern in the opposite
cellular side in relation to CGA antibody, which is the part of the
cytoplasm farthest from the nerve terminal. This particular dis-
tribution has been related with the structural distribution of
small clear-content vesicles observed with an electron micro-
scope (Ramírez et al. 2015). Secretory electron dense-core gran-
ules and small clear vesicles could be involved in two different
secretory pathways of MCs in dogs, as appears to be in MCs of
pig and neurons (Lundberg & Hokfelt 1983; García-Caballero
et al. 1989). Two secretory pathways have been proposed in
MCs: a Ca2+-dependent pathway that serves a mechanosensory
function and neurotransmitter release, and a Ca2+-indepen-
dent pathway that serves neuroendocrine functions and neuro-
peptide release (Boulais et al. 2009; Maksimovic et al. 2014).
Numbers, sizes, and electron densities of the granules and
clear vesicles can vary between MCs from the same or different
locations in the same animal or between different individuals
(Beiras et al. 1987; Ramírez et al. 2015). Although these anti-
bodies can identify the MCs in the skin, it appears to be not
completely adequate to perform extensive studies in cell
density or distribution because MCs with scant amounts of
granules or vesicles could be difficult to identify by immunohis-
tochemistry. In fact, CGA and Syn showed the lower intensity of
immunoreaction and lower amounts of MCs in serial sections.
In conclusion, the results of the present study highlight the
need to validate human commercial antibodies available for
identification of MCs for any particular immunohistochemical
study of density or mapping of this cell population in veterinary
species. Antibodies developed against CK20 appear to be the
most appropriate to effectively recognize MCs in the dog skin.
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